Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Dec 16, 2004


Bruker Falls 7 Percent as Rest of BCW Index Rises

The share price of Bruker BioSciences stock dropped 7 percent this week — the only loser among the 15 companies whose share prices are tracked in the BioCommerce Week Index.

Bruker closed the five-day tracking period ending at market close on Tuesday with its share price falling to $4.18, down from last week’s $4.51.

Invitrogen, following its 2005 guidance conference (see story, page 1), led the Index with a nearly 13-percent gain in its share price, closing Tuesday at $67.63, up from last week’s $60.12.

Harvard Bio, with a 10-percent gain, was the only other company’s whose share price saw double-digit growth., closing at $4.47, up from last week’s $4.06.

PerkinElmer, which said it would hold its 2005 guidance via conference call on Friday, ended the week with its share price improving 6 percent, closing at $22.70, up over last week’s $21.35.

General Electric’s stock price improved 5.8 percent on the week, closing at $37.38, up over $35.31 last week as CEO Jeff Immelt told analysts at the company’s guidance meeting on Tuesday that the company expects sales to grow 10 percent next year, and profits to rise 17 percent.

Molecular Devices shares improved 5.7 percent; Applied Biosystems moved to $21.10 from $20.09.

Beckman Coulter and Sigma-Aldrich closed up 4 percent, while Becton Dickinson saw a 3-percent increase.

Bio-Rad share prices finished up for the fifth consecutive week, improving 2.4 percent on the week. Thermo Electron was up 2 percent.

Stratagene and Agilent, which met analysts on Tuesday (see story page 6), improved 1.6 percent and 1.3 percent, respectively.

Overall, the index closed at $35.40, up 4.4 percent over last week’s $33.92 and outpaced the broad market indices with the Dow, the S&P 500, and the Nasdaq all up approximately 2 percent on the week. The Amex biotechnology index improved 5 percent on the week, while the Amex pharmaceutical index was up just under 2 percent.

— Mo Krochmal ([email protected])

File Attachments
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.